newsfilter
← Latest News
GlobeNewswire·

AC Immune to Participate in Upcoming Investor Conferences

AC Immune to Participate in Upcoming Investor Conferences Lausanne, Switzerland, March 4, 2025 – AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative